CN111867584A - 作为蛋白质精氨酸甲基转移酶的抑制剂的乙二胺-杂环衍生物 - Google Patents

作为蛋白质精氨酸甲基转移酶的抑制剂的乙二胺-杂环衍生物 Download PDF

Info

Publication number
CN111867584A
CN111867584A CN201980020505.5A CN201980020505A CN111867584A CN 111867584 A CN111867584 A CN 111867584A CN 201980020505 A CN201980020505 A CN 201980020505A CN 111867584 A CN111867584 A CN 111867584A
Authority
CN
China
Prior art keywords
alkyl
cycloalkyl
alkoxy
compound
cyano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980020505.5A
Other languages
English (en)
Chinese (zh)
Inventor
M·E·迪弗朗西斯科
P·琼斯
T·麦卡福斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The University of Texas System
Original Assignee
The University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The University of Texas System filed Critical The University of Texas System
Publication of CN111867584A publication Critical patent/CN111867584A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN201980020505.5A 2018-03-01 2019-03-01 作为蛋白质精氨酸甲基转移酶的抑制剂的乙二胺-杂环衍生物 Pending CN111867584A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862637147P 2018-03-01 2018-03-01
US62/637,147 2018-03-01
PCT/US2019/020395 WO2019169326A1 (en) 2018-03-01 2019-03-01 Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

Publications (1)

Publication Number Publication Date
CN111867584A true CN111867584A (zh) 2020-10-30

Family

ID=67767960

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980020505.5A Pending CN111867584A (zh) 2018-03-01 2019-03-01 作为蛋白质精氨酸甲基转移酶的抑制剂的乙二胺-杂环衍生物

Country Status (8)

Country Link
US (2) US11028083B2 (cg-RX-API-DMAC7.html)
EP (1) EP3758698A4 (cg-RX-API-DMAC7.html)
JP (1) JP7305664B2 (cg-RX-API-DMAC7.html)
CN (1) CN111867584A (cg-RX-API-DMAC7.html)
AU (1) AU2019226585A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020017541A2 (cg-RX-API-DMAC7.html)
CA (1) CA3092579A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019169326A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020017541A2 (pt) 2018-03-01 2020-12-22 Board Of Regents, The University Of Texas System Composto de fórmula estrutural i ou sal do mesmo, composição farmacêutica, método para inibição de prmt, método para modular expressão de gene, e método para tratamento de uma doença mediada por prmt
WO2022192527A1 (en) * 2021-03-12 2022-09-15 Board Of Regents, The University Of Texas System Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US20130059845A1 (en) * 2011-08-26 2013-03-07 Metabolex, Inc. Bicyclic agonists of gpr131 and uses thereof
US20140288124A1 (en) * 2013-03-14 2014-09-25 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US20140315904A1 (en) * 2013-03-14 2014-10-23 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
CN105339351A (zh) * 2013-03-14 2016-02-17 Epizyme股份有限公司 精氨酸甲基转移酶抑制剂及其用途
WO2017145013A1 (en) * 2016-02-23 2017-08-31 Pfizer Inc. 6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004149429A (ja) * 2002-10-29 2004-05-27 Takeda Chem Ind Ltd インドール化合物およびその用途
EP2221053A1 (de) * 2009-02-20 2010-08-25 Albert-Ludwigs-Universität Freiburg Pharmazeutische Zusammensetzung enthaltend Hemmstoffe der Proteinmethyltransferase I und deren Verwendung zur Behandlung von Tumorerkrankungen
WO2014153172A1 (en) 2013-03-14 2014-09-25 Epizyme, Inc. Pyrazole derivatives as prmt1 inhibitors and uses thereof
US9133189B2 (en) * 2013-03-14 2015-09-15 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
JP2016514164A (ja) 2013-03-14 2016-05-19 エピザイム,インコーポレイティド アルギニンメチルトランスフェラーゼ阻害剤としてのピラゾール誘導体およびその使用
EP3363434A1 (en) * 2013-03-14 2018-08-22 Epizyme Inc Arginine methyltransferase inhibitors and uses thereof
EP2970181B1 (en) * 2013-03-14 2017-06-07 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
EP2970135B1 (en) * 2013-03-14 2018-07-18 Epizyme, Inc. Pyrazole derivatives as prmt1 inhibitors and uses thereof
US20160039767A1 (en) 2013-03-14 2016-02-11 Epizyme, Inc. Pyrazole derivatives as prmt1 inhibitors and uses thereof
AU2015301196A1 (en) 2014-08-04 2017-01-12 Epizyme, Inc. PRMT5 inhibitors and uses thereof
US20170283400A1 (en) 2014-09-17 2017-10-05 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
WO2016044576A1 (en) 2014-09-17 2016-03-24 Epizyme, Inc. Salts, co-crystals, amorphous forms, and crystalline forms of an arginine methyltransferase inhibitor
US20170280720A1 (en) * 2014-09-17 2017-10-05 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
WO2016044626A1 (en) 2014-09-17 2016-03-24 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
WO2017136699A1 (en) 2016-02-05 2017-08-10 Epizyme, Inc Arginine methyltransferase inhibitors and uses thereof
BR112020017541A2 (pt) 2018-03-01 2020-12-22 Board Of Regents, The University Of Texas System Composto de fórmula estrutural i ou sal do mesmo, composição farmacêutica, método para inibição de prmt, método para modular expressão de gene, e método para tratamento de uma doença mediada por prmt

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002941A (en) * 1985-12-12 1991-03-26 Smithkline Beecham Corporation Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
US20130059845A1 (en) * 2011-08-26 2013-03-07 Metabolex, Inc. Bicyclic agonists of gpr131 and uses thereof
US20140288124A1 (en) * 2013-03-14 2014-09-25 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US20140315904A1 (en) * 2013-03-14 2014-10-23 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
CN105339351A (zh) * 2013-03-14 2016-02-17 Epizyme股份有限公司 精氨酸甲基转移酶抑制剂及其用途
WO2017145013A1 (en) * 2016-02-23 2017-08-31 Pfizer Inc. 6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds

Also Published As

Publication number Publication date
BR112020017541A2 (pt) 2020-12-22
EP3758698A1 (en) 2021-01-06
WO2019169326A1 (en) 2019-09-06
US11028083B2 (en) 2021-06-08
JP7305664B2 (ja) 2023-07-10
US20190270739A1 (en) 2019-09-05
CA3092579A1 (en) 2019-09-06
AU2019226585A1 (en) 2020-10-08
US20230027126A1 (en) 2023-01-26
EP3758698A4 (en) 2021-10-20
US11725008B2 (en) 2023-08-15
JP2021514999A (ja) 2021-06-17

Similar Documents

Publication Publication Date Title
AU2019263294B2 (en) Substituted heterocyclic inhibitors of PTPN11
CN115557974A (zh) Kras g12d抑制剂及其应用
AU2019245403B2 (en) Imidazopiperazine inhibitors of transcription activating proteins
CN105939997B (zh) 作为dlk抑制剂的吡唑衍生物及其用途
WO2023109883A1 (zh) 一类芳杂环取代的化合物及其制备方法和用途
WO2021219072A1 (zh) 作为kras抑制剂的杂环化合物的制备及其应用方法
WO2019158019A1 (zh) 嘧啶并环化合物及其制备方法和应用
WO2019174533A1 (zh) Pd-1/pd-l1类小分子抑制剂及其在药物中的应用
CN110088096A (zh) 作为泛素特异性蛋白酶7的抑制剂的哌啶衍生物
CN102388043A (zh) 组胺h3反相激动剂和拮抗剂及其使用方法
CN101903384A (zh) 作为蛋白激酶Cθ抑制剂的[1H-吡唑并[3,4-B]吡啶-4-基]-苯基或-吡啶-2-基衍生物
TW201605866A (zh) 可用作pim激酶抑制劑之呋喃并-及噻吩并-吡啶甲醯胺化合物
CN104918934A (zh) 3-取代的吡唑及其作为dlk抑制剂的用途
CN115515940A (zh) 用于治疗疾病的受体相互作用蛋白激酶i的抑制剂
JP2019528319A (ja) 疾患の処置のための二重ロイシンジッパー(dlk)キナーゼの阻害薬
CN107921044A (zh) 用于治疗疾病的gls1抑制剂
TW202417449A (zh) Cdk2抑制劑及使用彼等之方法
EP4484420A1 (en) Inhibitor of interaction between yap/taz and tead, preparation thereof, pharmaceutical composition thereof and use thereof
US11725008B2 (en) Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
TW202604527A (zh) 一種含氮雜環類化合物、其製備方法及其應用
EP4153601A1 (en) Competitive and noncompetitive inhibitors of the muscarinic acetylcholine receptor m5
CN120603818A (zh) Nlrp3抑制剂
WO2023151635A1 (zh) 基于喹唑啉取代戊二酰亚胺骨架的化合物及其应用
WO2022192527A1 (en) Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
CN117659023A (zh) 吡啶乙酰胺类衍生物、包含其的药物组合物及其医药用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20201030